MedPath

A study to see the dermatological efficacy of XXXXI on healthy ski

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000019447
Lead Sponsor
Kao Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1_Panelists who have a known allergy or sensitivity to any facial care product, facial moisturizer, facial cleanser, pore strip, or to any specific ingredient or fragrance used in these types of products. 2_Panelists having illnesses or diseases which in the opinion of the investigator, might interfere with the conduct of the study or the interpretation of results. Especially panelists with any skin irritation, skin condition (such as rosacea, eczema, atopic dermatitis, or psoriasis), or severe acne on their face. 3_Panelists who take OTC or prescription medications which, in the opinion of the investigator, might interfere with the conduct of the study or the interpretation of results. 4_Panelists who have used a topical antibiotic on their faces in the last two weeks. 5_Panelists under the care of a doctor or dermatologist taking prescription medication (topical or oral) for any facial skin issues. 6_Panelists who have started any type of estrogen or hormone therapy including birth control pills in the last four weeks and/or are planning to start them during the study. Panelists who are pregnant, planning to be pregnant, or breastfeeding 7_Panelists who have used pore strips on their faces in the last two weeks. 8_Panelists who have undergone chemical peeling on their faces in the last six months. 9_Panelists who have undergone laser therapy, or phototherapy on their faces in the last six months. 10_Panelists currently participating in, or scheduled to participate in, another facial study during the study period. 11_Panelists who work for, or have household members who work for, a manufacturer or advertiser of personal care products.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
valuation of the sebum content, the sebum composition, the gene expressions, the skin flora, the skin color and the dermatological assessment before the application of XXXXI and after the application of XXXXI for 4 and 6 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath